- Home
- DHT vs LIVN Comparison
DHT vs LIVN Comparison
Compare DHT & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DHT
- LIVN
- Stock Information
- Founded
- DHT 2005
- LIVN 1987
- Country
- DHT Bermuda
- LIVN United Kingdom
- Employees
- DHT N/A
- LIVN N/A
- Industry
- DHT Marine Transportation
- LIVN Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- DHT Consumer Discretionary
- LIVN Health Care
- Exchange
- DHT Nasdaq
- LIVN Nasdaq
- Market Cap
- DHT 1.7B
- LIVN 2.1B
- IPO Year
- DHT 2005
- LIVN 1993
- Fundamental
- Price
- DHT $11.02
- LIVN $43.70
- Analyst Decision
- DHT Strong Buy
- LIVN Strong Buy
- Analyst Count
- DHT 4
- LIVN 7
- Target Price
- DHT $13.75
- LIVN $59.29
- AVG Volume (30 Days)
- DHT 1.7M
- LIVN 515.4K
- Earning Date
- DHT 08-11-2025
- LIVN 08-06-2025
- Dividend Yield
- DHT 8.62%
- LIVN N/A
- EPS Growth
- DHT 4.76
- LIVN N/A
- EPS
- DHT 1.10
- LIVN N/A
- Revenue
- DHT $563,104,000.00
- LIVN $1,275,380,000.00
- Revenue This Year
- DHT N/A
- LIVN $8.02
- Revenue Next Year
- DHT $26.57
- LIVN $5.83
- P/E Ratio
- DHT $10.13
- LIVN N/A
- Revenue Growth
- DHT N/A
- LIVN 7.62
- 52 Week Low
- DHT $8.67
- LIVN $32.48
- 52 Week High
- DHT $12.32
- LIVN $57.35
- Technical
- Relative Strength Index (RSI)
- DHT 45.40
- LIVN 43.39
- Support Level
- DHT $10.79
- LIVN $43.60
- Resistance Level
- DHT $11.25
- LIVN $47.42
- Average True Range (ATR)
- DHT 0.23
- LIVN 1.26
- MACD
- DHT -0.01
- LIVN -0.35
- Stochastic Oscillator
- DHT 41.22
- LIVN 11.78
About DHT DHT Holdings Inc.
DHT Holdings Inc is a crude oil tanker company. Its fleet trades internationally and consists of crude oil tankers in the VLCC. The group generates revenues from time charter and spot market operations. It operates through integrated management companies in Monaco, Norway, Singapore, and India. The company generates the majority of its revenue from the shipping revenues.
About LIVN LivaNova PLC
UK-based Livanova was born of a combination between Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, Livanova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives roughly half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.